Fatal drug-drug interaction of brivudine and capecitabine

Acta Oncologica

Volumn 48, Issue 4, 2009, Pages 631-633

  Rätz Bravo, Alexandra E ^a   Hofer, Silvia ^b   Krähenübhl, Stephan ^a   Ludwig, Christian ^b  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b St Claraspital AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

5 (2 BROMOVINYL) 2' DEOXYURIDINE; CAPECITABINE; OPIATE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; ANTINEOPLASTIC ANTIMETABOLITE; ANTIVIRUS AGENT; BROXURIDINE; DEOXYCYTIDINE; DRUG DERIVATIVE; FLUOROURACIL;

AGED; CASE REPORT; COLORECTAL CANCER; DRUG CROSS REACTIVITY; DRUG ERUPTION; EDEMA; FATALITY; FEMALE; HERPES ZOSTER; HUMAN; LETTER; LEUKOPENIA; METASTASIS; MOUTH INFLAMMATION; PAIN; PRIORITY JOURNAL; STEVENS JOHNSON SYNDROME; THROMBOCYTOPENIA; COLORECTAL TUMOR; DRUG INTERACTION; DRUG SURVEILLANCE PROGRAM; DRUG TOXICITY; METABOLISM; SWITZERLAND;

ADVERSE DRUG REACTION REPORTING SYSTEMS; AGED, 80 AND OVER; ANTIMETABOLITES, ANTINEOPLASTIC; ANTIVIRAL AGENTS; BROMODEOXYURIDINE; COLORECTAL NEOPLASMS; DEOXYCYTIDINE; DRUG INTERACTIONS; DRUG TOXICITY; FATAL OUTCOME; FEMALE; FLUOROURACIL; HERPES ZOSTER; HUMANS; SWITZERLAND;

EID: 65549166340     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.1080/02841860802660502     Document Type: Letter

References (6)

1. Dooley M, Goa KL. Capecitabine. Drugs 1999;/58:/69-76.
2. Keam SJ, Chapman TM, Figgitt DP. Brivudin (bromovinyl deoxyuridine). Drugs 2004;64:2091-7; Discussion 2098-9.
3. Keizer HJ, De Bruijn EA, Tjaden UR, De Clercq E. Inhibition of fluorouracil catabolism in cancer patients by the antiviral agent (E)-5-(2-bromovinyl)-2?-deoxyuridine. J Cancer Res Clin Oncol 1994;/120:/545-9.
4. Okuda H, Ogura K, Kato A, Takubo H, Watabe T. A possible mechanism of eighteen patient deaths caused by interactions of sorivudine, a new antiviral drug, with oral 5-fluorouracil prodrugs. J Pharmacol Exp Ther 1998;/287:/791-9.
5. De Clercq E. (E)-5-(2-bromovinyl)-2?-deoxyuridine (BVDU). Med Res Rev 2005;/25:/1-20.
6. Marston E, Leibundgut G, Kühne M, Rätz Bravo A, Hofer S, Ludwig C. Eine tödliche Arzneimittelinteraktion. Schweiz Med Forum 2006;/6:/350-2.